Baillie Gifford & Co. reduced its stake in shares of LiveRamp Holdings, Inc. (NYSE:RAMP - Free Report) by 2.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,358,074 shares of the company's stock after selling 38,839 shares during the quarter. Baillie Gifford & Co. owned about 2.04% of LiveRamp worth $33,653,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. EVR Research LP acquired a new stake in shares of LiveRamp during the second quarter worth about $5,879,000. Vanguard Group Inc. increased its position in LiveRamp by 1.4% during the first quarter. Vanguard Group Inc. now owns 8,174,985 shares of the company's stock worth $282,037,000 after buying an additional 115,685 shares during the period. Assenagon Asset Management S.A. lifted its stake in LiveRamp by 32.0% in the second quarter. Assenagon Asset Management S.A. now owns 264,470 shares of the company's stock valued at $8,183,000 after buying an additional 64,155 shares during the last quarter. Lord Abbett & CO. LLC lifted its stake in LiveRamp by 41.1% in the first quarter. Lord Abbett & CO. LLC now owns 323,313 shares of the company's stock valued at $11,154,000 after buying an additional 94,111 shares during the last quarter. Finally, Seven Eight Capital LP acquired a new stake in shares of LiveRamp in the first quarter valued at approximately $1,302,000. 93.83% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several analysts recently commented on the stock. Benchmark reduced their price target on shares of LiveRamp from $48.00 to $42.00 and set a "buy" rating for the company in a research report on Thursday, November 7th. Wells Fargo & Company started coverage on LiveRamp in a report on Monday, October 28th. They set an "equal weight" rating and a $25.00 price target on the stock. Craig Hallum reduced their price objective on LiveRamp from $55.00 to $43.00 and set a "buy" rating for the company in a research note on Thursday, August 8th. Evercore ISI decreased their price objective on LiveRamp from $50.00 to $40.00 and set an "outperform" rating for the company in a research report on Thursday, August 8th. Finally, Macquarie reissued an "outperform" rating and issued a $43.00 target price on shares of LiveRamp in a report on Thursday, November 7th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $41.14.
Check Out Our Latest Report on LiveRamp
LiveRamp Price Performance
Shares of RAMP stock traded up $0.31 during trading hours on Wednesday, reaching $28.80. 489,920 shares of the company's stock were exchanged, compared to its average volume of 649,113. The company's 50 day moving average is $25.19 and its two-hundred day moving average is $28.17. The company has a market cap of $1.88 billion, a P/E ratio of 575.52 and a beta of 0.96. LiveRamp Holdings, Inc. has a 1 year low of $21.45 and a 1 year high of $42.66.
LiveRamp (NYSE:RAMP - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.51 EPS for the quarter, beating analysts' consensus estimates of $0.37 by $0.14. LiveRamp had a return on equity of 1.25% and a net margin of 0.40%. The company had revenue of $185.00 million during the quarter, compared to the consensus estimate of $176.16 million. During the same quarter last year, the company earned $0.21 earnings per share. LiveRamp's quarterly revenue was up 15.6% compared to the same quarter last year. As a group, analysts predict that LiveRamp Holdings, Inc. will post 0.37 EPS for the current fiscal year.
Insider Buying and Selling at LiveRamp
In related news, Director Debora B. Tomlin sold 9,765 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $25.07, for a total value of $244,808.55. Following the sale, the director now directly owns 24,509 shares of the company's stock, valued at approximately $614,440.63. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Debora B. Tomlin sold 9,765 shares of the company's stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $25.07, for a total value of $244,808.55. Following the sale, the director now owns 24,509 shares of the company's stock, valued at approximately $614,440.63. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Kimberly Bloomston sold 4,000 shares of the stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $25.17, for a total value of $100,680.00. Following the sale, the insider now owns 117,247 shares in the company, valued at approximately $2,951,106.99. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 19,538 shares of company stock valued at $495,471. Corporate insiders own 3.39% of the company's stock.
LiveRamp Profile
(
Free Report)
LiveRamp Holdings, Inc, a technology company, operates a data collaboration platform in the United States, Europe, the Asia-Pacific, and internationally. The company operates LiveRamp Data Collaboration platform enables an organization to unify customer and prospect data to build a single view of the customer in a way that protects consumer privacy.
Read More
Before you consider LiveRamp, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LiveRamp wasn't on the list.
While LiveRamp currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.